Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of Migraine
Condition:   Migraine Interventions:   Drug: Rizatriptan 10 mg + Naproxen 550mg;   Drug: Maxalt 10Mg Tablet;   Drug: Flanax 550mg;   Drug: Placebo oral tablet Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2020 Category: Research Source Type: clinical trials

Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection
Condition:   COVID-19 Interventions:   Drug: 1: Naproxen;   Drug: 2: Standard of care Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2020 Category: Research Source Type: clinical trials